DIBENZ[A]ANTHRACENE (1,2,5,6-)
Citation:
Author(s)
Dickerson, Richard L., Michael J. Hooper, Nicholas W. Gard, George P. Cobb and Ronald J. Kendall
Year
Chemical |
Endpoint Value |
Endpoint Description |
Sex |
Life Cycle Stage |
Sample Size |
Location |
Type |
Age-Specific |
Lab |
DIBENZ[A]ANTHRACENE (1,2,5,6-) |
0.048 mg/kg/d |
ED50 for immunosuppression, measured as suppression of plaque forming cell response |
Male |
Juvenile |
Not Reported |
|
Toxicity Factor Datasets |
7 - 8 wk |
Laboratory |
DIBENZ[A]ANTHRACENE (1,2,5,6-) |
0.85 mg/kg/d |
ED50 for ethoxyresorufin-O-dealkylase (EROD) activity |
Male |
Juvenile |
Not Reported |
|
Toxicity Factor Datasets |
7 - 8 wk |
Laboratory |
Citation:
Chemical |
Endpoint Value |
Endpoint Description |
Sex |
Life Cycle Stage |
Sample Size |
Location |
Type |
Age-Specific |
California Counties |
Condition |
Lab |
DIBENZ[A]ANTHRACENE (1,2,5,6-) |
5 |
description |
Both Male and Female |
Adult |
sample size |
location |
Toxicity Factor Datasets |
age |
Alameda |
condition |
Laboratory |
Comment